Acadia Pharmaceuticals, Inc. (ACAD) Posts Q2 Loss of 11c/Share

August 6, 2013 4:03 PM

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) reported Q2 EPS of ($0.11) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found